Table 1.
Demographic data and major underlying diseases of patients in two treatment groups – full analysis set.
| Characteristics | Acute uncomplicated urinary tract infection |
Complicated urinary tract infection |
||
|---|---|---|---|---|
| Sitafloxacin (n = 69) | Levofloxacin (n = 71) | Sitafloxacin (n = 34) | Levofloxacin (n = 30) | |
| Age, years (mean ± SD) | 40.6 ± 13.84 | 37.6 ± 13.67 | 47.9 ± 14.62 | 47.2 ± 14.60 |
| Sex, males, n (%) | 0 | 0 | 10 (29.4) | 9 (30.0) |
| Body mass index, kg/m2 (mean ± SD) | 21.69 ± 3.061 | 22.40 ± 3.161 | 23.70 ± 3.719 | 23.69 ± 3.737 |
| Underlying disease, n (%) | ||||
| Nephrolithiasis | 0 | 0 | 7 (20.6) | 6 (20.0) |
| Glomerular nephritis | 0 | 0 | 6 (17.6) | 4 (13.4) |
| Diabetes mellitus | 0 | 0 | 8 (23.5) | 5 (16.7) |
| Hyperlipidaemia | 1 (1.4) | 0 | 3 (8.8) | 2 (6.7) |
| Hypertension | 2 (2.9) | 4 (5.6) | 8 (23.5) | 6 (20.0) |
| Hydronephrosis | 0 | 0 | 1 (2.9) | 1 (3.3) |
| Nephrotic syndrome | 0 | 0 | 0 | 1 (3.3) |
| Renal tubular acidosis | 0 | 0 | 0 | 1 (3.3) |
SD: standard deviation.